[ad_1] <br><a href="https://news.google.com/atom/articles/CBMiV2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9wcmVzcy1yZWxlYXNlLWR1cGl4ZW50LWR1cGlsdW1hYi1icmVha2luZy0xODE3MDAxMTIuaHRtbNIBX2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL3ByZXNzLXJlbGVhc2UtZHVwaXhlbnQtZHVwaWx1bWFiLWJyZWFraW5nLTE4MTcwMDExMi5odG1s?oc=5" target="_blank" rel="noopener">Press Release: Dupixent® (dupilumab) late-breaking Phase 3 COPD results presented at ATS and simultaneously published in the New England Journal of Medicine</a> <font color="#6f6f6f">Yahoo Finance</font> <br>[ad_2] <br><a href="https://news.google.com/atom/articles/CBMiV2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9wcmVzcy1yZWxlYXNlLWR1cGl4ZW50LWR1cGlsdW1hYi1icmVha2luZy0xODE3MDAxMTIuaHRtbNIBX2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL3ByZXNzLXJlbGVhc2UtZHVwaXhlbnQtZHVwaWx1bWFiLWJyZWFraW5nLTE4MTcwMDExMi5odG1s?oc=5">Source link </a>
Discussion about this post